TetraLogic Pharmaceuticals Corp Financials

We advise to exercise TetraLogic Pharmaceuticals fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of TetraLogic Pharmaceuticals as well as the relationship between them. We were able to break down and interpolate data for thirty available drivers for TetraLogic Pharmaceuticals Corp, which can be compared to its competition.
  

TetraLogic Pharmaceuticals Stock Summary

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Tetralogic Pharmaceu operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 29 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS88165U1097
CUSIP88165U109
LocationPennsylvania; U.S.A
Business Address343 Phoenixville Pike,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.tetralogicpharma.com
Phone610 889 9900
CurrencyUSD - US Dollar

TetraLogic Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that TetraLogic Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that TetraLogic Pharmaceuticals reports annually and quarterly.

TetraLogic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining TetraLogic Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare TetraLogic Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TetraLogic Pharmaceuticals competition to find correlations between indicators driving TetraLogic Pharmaceuticals's intrinsic value. More Info.
TetraLogic Pharmaceuticals Corp is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TetraLogic Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in TetraLogic Pink Sheet

If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance